Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | PXMD | Common Stock | 385K | Aug 12, 2022 | Direct | F1, F2 | |||||
holding | PXMD | Common Stock | 7.24M | Aug 12, 2022 | TardiMed Sciences, LLC | F3 |
Id | Content |
---|---|
F1 | Includes restricted stock units that vest as described in the Company's Registration Statement on Form S-1 (File No. 333-239676). |
F2 | Due to administrative error, 24,000 restricted stock units were omitted from the reporting person's Form 3. |
F3 | The reporting person is the Managing Partner of TardiMed Sciences, LLC and has sole voting and dispositive control over the shares of Common Stock held by the entity. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |